Connect Biopharma : INFORMATION CONTAINED IN THIS REPORT ON

Document



















UNITED STATES


SECURITIES...

Related Keywords

California , United States , San Diego , San Francisco , Irvine , Washington , Kleanthisg Xanthopoulos , Zheng Wei , David Szekeres , Patara Pharma , Steven Chan , Sanford Burnham Preby , Wubin Pan , University Of California , Counsel At Regulus Therapeutics Inc , Warner Lambert Company , Exchange Commission , Roivant Sciences , Heron Therapeutics Inc , Agouron Pharmaceuticals Inc , Company Registration Statement On Form , Exchange Commission On , Edico Genome Inc , Pfizer Inc , Head Of Finance Heron Therapeutics Inc , Nasdaq , Duke University School Of Law , Commission File Number , Securities Exchange , Ardea Biosciences Inc , Nasdaq Stock Market , Life Technologies Corporation , Biopharma Holdings Limited The Company , Pfizer Global Research , Kiniksa Pharmaceuticals Ltd , Biopharma Holdings , File Number , Camino Real , Regulationst Rule , Certain Officers , Connect Biopharma Holdings Limited , Chief Executive Officer , Barry Quart , Heron Therapeutics , Ardea Biosciences , Senior Vice President , Agouron Pharmaceuticals , Kiniksa Pharmaceuticals , Indemnification Agreement , Registration Statement , Regulations K , Securities Act , Chief Operating Officer , Chief Business Officer , Principal Financial Officer , General Counsel , Regulus Therapeutics , Thermo Fisher Scientific , Edico Genome , Duke University School , Inducement Incentive Award Plan , Incentive Plan , Inducement Plan , Nasdaq Listing , Nasdaq Listing Rules , Connect Biopharm , Securities Exchange Act ,